HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco DiBonaventura Selected Research

Biological Therapy

1/2022Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco DiBonaventura Research Topics

Disease

13Atopic Dermatitis (Atopic Eczema)
08/2022 - 01/2020
5Eczema
01/2022 - 01/2020
4Ulcerative Colitis
01/2022 - 01/2021
4Infections
01/2022 - 01/2019
3Neoplasms (Cancer)
01/2021 - 06/2018
3Prostatic Neoplasms (Prostate Cancer)
10/2017 - 11/2016
2Nausea
10/2021 - 01/2021
2Pruritus (Itching)
07/2021 - 01/2021
2Skin Neoplasms (Skin Cancer)
01/2021 - 11/2009
2Chorea (Rheumatic Chorea)
01/2018 - 01/2018
2Huntington Disease (Huntington's Disease)
01/2018 - 01/2018
2Sleep Initiation and Maintenance Disorders (Insomnia)
07/2016 - 01/2015
2Type 2 Diabetes Mellitus (MODY)
01/2014 - 02/2011
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1Hemorrhage
01/2021
1Herpes Zoster
01/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021
1Acne Vulgaris
01/2021
1Opportunistic Infections (Opportunistic Infection)
01/2021
1Pulmonary Embolism
01/2021
1Gaucher Disease (Gaucher's Disease)
01/2019
1Neoplasm Metastasis (Metastasis)
10/2017
1Osteoporosis
07/2016
1Hypertension (High Blood Pressure)
07/2016
1Polycythemia Vera
01/2015
1Bipolar Disorder (Manic Depressive Psychosis)
07/2012
1Pain (Aches)
07/2012
1Schizophrenia (Dementia Praecox)
07/2012
1Communicable Diseases (Infectious Diseases)
01/2012

Drug/Important Bio-Agent (IBA)

10abrocitinibIBA
08/2022 - 01/2020
4Janus Kinase 1IBA
08/2022 - 01/2020
4dupilumabIBA
01/2022 - 01/2021
3Immunoglobulin A (IgA)IBA
10/2021 - 01/2020
2Janus Kinase InhibitorsIBA
01/2021 - 01/2021
2tofacitinibIBA
01/2021 - 01/2021
2Tetrabenazine (Nitoman)FDA Link
01/2018 - 01/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1Biological ProductsIBA
12/2021
1CytokinesIBA
10/2021
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
07/2021
1omega-Chloroacetophenone (Mace)IBA
01/2021
1Interleukin-13IBA
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1SteroidsIBA
01/2019
1Pharmaceutical PreparationsIBA
06/2018
1CholesterolIBA
07/2016
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2015
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2014
1Insulin (Novolin)FDA Link
01/2014
1Antipsychotic Agents (Antipsychotics)IBA
07/2012
1Aripiprazole (Abilify)FDA Link
07/2012
1VaccinesIBA
01/2012
1Hypoglycemic Agents (Hypoglycemics)IBA
02/2011
1Sunscreening Agents (Sunscreens)IBA
11/2009

Therapy/Procedure

8Therapeutics
01/2022 - 01/2018
3Castration
10/2017 - 11/2016
1Drug Tapering
01/2022
1Retreatment
01/2022
1Biological Therapy
01/2022
1Phototherapy (Light Therapy)
01/2022
1Subcutaneous Injections
10/2021
1Enzyme Replacement Therapy
01/2019
1Intravenous Administration
01/2019
1Activities of Daily Living (ADL)
01/2018
1Aftercare (After-Treatment)
01/2015
1Protective Clothing
11/2009